LIFCO-B Lifco AB (publ)
Lifco AB (publ) engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Finland, Germany, rest of Europe, the United Kingdom, Asia, Australia, Italy, North America, and internationally. It is involved in the distribution of dental equipment, such as denture attachments, disinfectants, saliva ejectors, bite registration and dental impression materials, bonding agents, and other consumables, as well as develops and sells medical record systems. The company also operates dental laboratory; and offers technical and software services. In addition, it develops, manufactures, and sells demolition robots, forest machines, crane and excavator attachments to heavy machine manufacturing, construction, forestry, nuclear, cement, and process industries. Further, the company offers machinery and equipment for electrical installations and electricity production, electrical equipment, equipment for recycling of various materials, and interiors for service vehicles. Additionally, it provides contract manufacturing, such as electronic components, stainless steel, and galvanized products; environmental technology; infrastructure products in the areas of electrification, LED-lighting, lift safety, relining, lightning protection, measuring instruments, and telecommunication; special products, including coffee machines, cartooning and sleeving solutions, special instruments, and clothing; and transportation products comprising tarpaulin systems, advanced lifting systems, equipment for ground service of aircrafts, light bars for trucks, and vehicle racking systems for service vans. The company was founded in 1946 and is based in Enköping, Sweden. Lifco AB (publ) is a subsidiary of Carl Bennet AB.…
Industry Peers
ConglomeratesKey Statistics
About Lifco (STO: LIFCO-B)
›
Lifco (STO: LIFCO-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Conglomerates industry, part of the Industrials sector, and reports about 8,166 employees.
The shares were at 283.60 SEK on 19 November 2026, down 18.8% over 52 weeks. Its 52-week range is 268.20 SEK to 368.40 SEK: the price is 23.0% below the high and 5.7% above the low.
At a market capitalisation of 128.82B SEK, it trades at 32.7 times trailing earnings and 35.5 times forward earnings. The median trailing P/E of its 15 largest Conglomerates peers is 16.5, a premium of 99% for LIFCO-B. It pays a dividend yielding 0.95% (it pays out 31% of its earnings), against a median of 1.26% among the dividend payers in that peer group.
Lifco reports return on equity of 19.0%, an operating margin of 19.0% and revenue up 8.3% year over year.
Its debt exceeds its cash by 9.57B SEK, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 8 analysts cover the stock, with an average rating of Buy; their mean price target of 319.63 SEK is 12.7% above the current price. The next earnings report is expected on 29 January 2027.